|
|||||||
| |||||||
| |||||||
1 | AN ACT concerning criminal law.
| ||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||
3 | represented in the General Assembly:
| ||||||
4 | Section 5. The Illinois Controlled Substances Act is | ||||||
5 | amended by changing Section 204 as follows:
| ||||||
6 | (720 ILCS 570/204) (from Ch. 56 1/2, par. 1204)
| ||||||
7 | Sec. 204. (a) The controlled substances listed in this | ||||||
8 | Section are
included in Schedule I.
| ||||||
9 | (b) Unless specifically excepted or unless listed in | ||||||
10 | another
schedule, any of the following opiates, including their | ||||||
11 | isomers,
esters, ethers, salts, and salts of isomers, esters, | ||||||
12 | and ethers,
whenever the existence of such isomers, esters, | ||||||
13 | ethers and salts is
possible within the specific chemical | ||||||
14 | designation:
| ||||||
15 | (1) Acetylmethadol;
| ||||||
16 | (1.1) Acetyl-alpha-methylfentanyl
| ||||||
17 | (N-[1-(1-methyl-2-phenethyl)-
| ||||||
18 | 4-piperidinyl]-N-phenylacetamide);
| ||||||
19 | (2) Allylprodine;
| ||||||
20 | (3) Alphacetylmethadol, except
| ||||||
21 | levo-alphacetylmethadol (also known as levo-alpha-
| ||||||
22 | acetylmethadol, levomethadyl acetate, or LAAM);
| ||||||
23 | (4) Alphameprodine;
|
| |||||||
| |||||||
1 | (5) Alphamethadol;
| ||||||
2 | (6) Alpha-methylfentanyl
| ||||||
3 | (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
| ||||||
4 | propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
| ||||||
5 | propanilido) piperidine;
| ||||||
6 | (6.1) Alpha-methylthiofentanyl
| ||||||
7 | (N-[1-methyl-2-(2-thienyl)ethyl-
| ||||||
8 | 4-piperidinyl]-N-phenylpropanamide);
| ||||||
9 | (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
| ||||||
10 | (7) 1-methyl-4-phenyl-4-proprionoxypiperidine (MPPP);
| ||||||
11 | (7.1) PEPAP
| ||||||
12 | (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
| ||||||
13 | (8) Benzethidine;
| ||||||
14 | (9) Betacetylmethadol;
| ||||||
15 | (9.1) Beta-hydroxyfentanyl
| ||||||
16 | (N-[1-(2-hydroxy-2-phenethyl)-
| ||||||
17 | 4-piperidinyl]-N-phenylpropanamide);
| ||||||
18 | (10) Betameprodine;
| ||||||
19 | (11) Betamethadol;
| ||||||
20 | (12) Betaprodine;
| ||||||
21 | (13) Clonitazene;
| ||||||
22 | (14) Dextromoramide;
| ||||||
23 | (15) Diampromide;
| ||||||
24 | (16) Diethylthiambutene;
| ||||||
25 | (17) Difenoxin;
| ||||||
26 | (18) Dimenoxadol;
|
| |||||||
| |||||||
1 | (19) Dimepheptanol;
| ||||||
2 | (20) Dimethylthiambutene;
| ||||||
3 | (21) Dioxaphetylbutyrate;
| ||||||
4 | (22) Dipipanone;
| ||||||
5 | (23) Ethylmethylthiambutene;
| ||||||
6 | (24) Etonitazene;
| ||||||
7 | (25) Etoxeridine;
| ||||||
8 | (26) Furethidine;
| ||||||
9 | (27) Hydroxpethidine;
| ||||||
10 | (28) Ketobemidone;
| ||||||
11 | (29) Levomoramide;
| ||||||
12 | (30) Levophenacylmorphan;
| ||||||
13 | (31) 3-Methylfentanyl
| ||||||
14 | (N-[3-methyl-1-(2-phenylethyl)-
| ||||||
15 | 4-piperidyl]-N-phenylpropanamide);
| ||||||
16 | (31.1) 3-Methylthiofentanyl
| ||||||
17 | (N-[(3-methyl-1-(2-thienyl)ethyl-
| ||||||
18 | 4-piperidinyl]-N-phenylpropanamide);
| ||||||
19 | (32) Morpheridine;
| ||||||
20 | (33) Noracymethadol;
| ||||||
21 | (34) Norlevorphanol;
| ||||||
22 | (35) Normethadone;
| ||||||
23 | (36) Norpipanone;
| ||||||
24 | (36.1) Para-fluorofentanyl
| ||||||
25 | (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
| ||||||
26 | 4-piperidinyl]propanamide);
|
| |||||||
| |||||||
1 | (37) Phenadoxone;
| ||||||
2 | (38) Phenampromide;
| ||||||
3 | (39) Phenomorphan;
| ||||||
4 | (40) Phenoperidine;
| ||||||
5 | (41) Piritramide;
| ||||||
6 | (42) Proheptazine;
| ||||||
7 | (43) Properidine;
| ||||||
8 | (44) Propiram;
| ||||||
9 | (45) Racemoramide;
| ||||||
10 | (45.1) Thiofentanyl
| ||||||
11 | (N-phenyl-N-[1-(2-thienyl)ethyl-
| ||||||
12 | 4-piperidinyl]-propanamide);
| ||||||
13 | (46) Tilidine;
| ||||||
14 | (47) Trimeperidine;
| ||||||
15 | (48) Beta-hydroxy-3-methylfentanyl (other name:
| ||||||
16 | N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
| ||||||
17 | N-phenylpropanamide).
| ||||||
18 | (c) Unless specifically excepted or unless listed in | ||||||
19 | another
schedule, any of the following opium derivatives, its | ||||||
20 | salts, isomers
and salts of isomers, whenever the existence of | ||||||
21 | such salts, isomers and
salts of isomers is possible within the | ||||||
22 | specific chemical designation:
| ||||||
23 | (1) Acetorphine;
| ||||||
24 | (2) Acetyldihydrocodeine;
| ||||||
25 | (3) Benzylmorphine;
| ||||||
26 | (4) Codeine methylbromide;
|
| |||||||
| |||||||
1 | (5) Codeine-N-Oxide;
| ||||||
2 | (6) Cyprenorphine;
| ||||||
3 | (7) Desomorphine;
| ||||||
4 | (8) Diacetyldihydromorphine (Dihydroheroin);
| ||||||
5 | (9) Dihydromorphine;
| ||||||
6 | (10) Drotebanol;
| ||||||
7 | (11) Etorphine (except hydrochloride salt);
| ||||||
8 | (12) Heroin;
| ||||||
9 | (13) Hydromorphinol;
| ||||||
10 | (14) Methyldesorphine;
| ||||||
11 | (15) Methyldihydromorphine;
| ||||||
12 | (16) Morphine methylbromide;
| ||||||
13 | (17) Morphine methylsulfonate;
| ||||||
14 | (18) Morphine-N-Oxide;
| ||||||
15 | (19) Myrophine;
| ||||||
16 | (20) Nicocodeine;
| ||||||
17 | (21) Nicomorphine;
| ||||||
18 | (22) Normorphine;
| ||||||
19 | (23) Pholcodine;
| ||||||
20 | (24) Thebacon.
| ||||||
21 | (d) Unless specifically excepted or unless listed in | ||||||
22 | another
schedule, any material, compound, mixture, or | ||||||
23 | preparation which contains
any quantity of the following | ||||||
24 | hallucinogenic substances, or which
contains any of its salts, | ||||||
25 | isomers and salts of isomers, whenever the
existence of such | ||||||
26 | salts, isomers, and salts of isomers is possible
within the |
| |||||||
| |||||||
1 | specific chemical designation (for the purposes of this
| ||||||
2 | paragraph only, the term "isomer" includes the optical, | ||||||
3 | position and
geometric isomers):
| ||||||
4 | (1) 3,4-methylenedioxyamphetamine
| ||||||
5 | (alpha-methyl,3,4-methylenedioxyphenethylamine,
| ||||||
6 | methylenedioxyamphetamine, MDA);
| ||||||
7 | (1.1) Alpha-ethyltryptamine
| ||||||
8 | (some trade or other names: etryptamine;
| ||||||
9 | MONASE; alpha-ethyl-1H-indole-3-ethanamine;
| ||||||
10 | 3-(2-aminobutyl)indole; a-ET; and AET);
| ||||||
11 | (2) 3,4-methylenedioxymethamphetamine (MDMA);
| ||||||
12 | (2.1) 3,4-methylenedioxy-N-ethylamphetamine
| ||||||
13 | (also known as: N-ethyl-alpha-methyl-
| ||||||
14 | 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
| ||||||
15 | and MDEA);
| ||||||
16 | (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
| ||||||
17 | (4) 3,4,5-trimethoxyamphetamine (TMA);
| ||||||
18 | (5) (Blank);
| ||||||
19 | (6) Diethyltryptamine (DET);
| ||||||
20 | (7) Dimethyltryptamine (DMT);
| ||||||
21 | (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
| ||||||
22 | (9) Ibogaine (some trade and other names:
| ||||||
23 | 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
| ||||||
24 | 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
| ||||||
25 | indole; Tabernanthe iboga);
| ||||||
26 | (10) Lysergic acid diethylamide;
|
| |||||||
| |||||||
1 | (10.5) Salvia divinorum (meaning all parts of the plant | ||||||
2 | presently classified
botanically as Salvia divinorum, | ||||||
3 | whether growing or not, the
seeds thereof, any extract from | ||||||
4 | any part of that plant, and every compound,
manufacture, | ||||||
5 | salts, isomers, and salts of
isomers whenever the existence | ||||||
6 | of such salts, isomers, and salts of
isomers is possible | ||||||
7 | within the specific chemical designation, derivative, | ||||||
8 | mixture, or preparation of that plant, its
seeds or | ||||||
9 | extracts);
| ||||||
10 | (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
| ||||||
11 | (12) Peyote (meaning all parts of the plant presently | ||||||
12 | classified
botanically as Lophophora williamsii
williemaii
| ||||||
13 | Lemaire, whether growing or not, the
seeds thereof, any | ||||||
14 | extract from any part of that plant, and every compound,
| ||||||
15 | manufacture, salts, derivative, mixture, or preparation of | ||||||
16 | that plant, its
seeds or extracts);
| ||||||
17 | (13) N-ethyl-3-piperidyl benzilate (JB 318);
| ||||||
18 | (14) N-methyl-3-piperidyl benzilate;
| ||||||
19 | (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
| ||||||
20 | (also known as N-hydroxy-alpha-methyl-
| ||||||
21 | 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
| ||||||
22 | (15) Parahexyl; some trade or other names:
| ||||||
23 | 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
| ||||||
24 | dibenzo (b,d) pyran; Synhexyl;
| ||||||
25 | (16) Psilocybin;
| ||||||
26 | (17) Psilocyn;
|
| |||||||
| |||||||
1 | (18) Alpha-methyltryptamine (AMT);
| ||||||
2 | (19) 2,5-dimethoxyamphetamine
| ||||||
3 | (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
| ||||||
4 | (20) 4-bromo-2,5-dimethoxyamphetamine
| ||||||
5 | (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
| ||||||
6 | 4-bromo-2,5-DMA);
| ||||||
7 | (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
| ||||||
8 | Some trade or other names: 2-(4-bromo-
| ||||||
9 | 2,5-dimethoxyphenyl)-1-aminoethane;
| ||||||
10 | alpha-desmethyl DOB, 2CB, Nexus;
| ||||||
11 | (21) 4-methoxyamphetamine
| ||||||
12 | (4-methoxy-alpha-methylphenethylamine;
| ||||||
13 | paramethoxyamphetamine; PMA);
| ||||||
14 | (22) (Blank);
| ||||||
15 | (23) Ethylamine analog of phencyclidine.
| ||||||
16 | Some trade or other names:
| ||||||
17 | N-ethyl-1-phenylcyclohexylamine,
| ||||||
18 | (1-phenylcyclohexyl) ethylamine,
| ||||||
19 | N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
| ||||||
20 | (24) Pyrrolidine analog of phencyclidine. Some trade | ||||||
21 | or other names:
1-(1-phenylcyclohexyl) pyrrolidine, PCPy, | ||||||
22 | PHP;
| ||||||
23 | (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
| ||||||
24 | (26) 2,5-dimethoxy-4-ethylamphetamine
| ||||||
25 | (another name: DOET);
| ||||||
26 | (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
|
| |||||||
| |||||||
1 | (another name: TCPy);
| ||||||
2 | (28) (Blank);
| ||||||
3 | (29) Thiophene analog of phencyclidine (some trade
| ||||||
4 | or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
| ||||||
5 | 2-thienyl analog of phencyclidine; TPCP; TCP);
| ||||||
6 | (30) Bufotenine (some trade or other names:
| ||||||
7 | 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
| ||||||
8 | 3-(2-dimethylaminoethyl)-5-indolol;
| ||||||
9 | 5-hydroxy-N,N-dimethyltryptamine;
| ||||||
10 | N,N-dimethylserotonin; mappine).
| ||||||
11 | (e) Unless specifically excepted or unless listed in | ||||||
12 | another
schedule, any material, compound, mixture, or | ||||||
13 | preparation which contains
any quantity of the following | ||||||
14 | substances having a depressant effect on
the central nervous | ||||||
15 | system, including its salts, isomers, and salts of
isomers | ||||||
16 | whenever the existence of such salts, isomers, and salts of
| ||||||
17 | isomers is possible within the specific chemical designation:
| ||||||
18 | (1) mecloqualone;
| ||||||
19 | (2) methaqualone; and
| ||||||
20 | (3) gamma hydroxybutyric acid.
| ||||||
21 | (f) Unless specifically excepted or unless listed in | ||||||
22 | another schedule,
any material, compound, mixture, or | ||||||
23 | preparation which contains any quantity
of the following | ||||||
24 | substances having a stimulant effect on the central nervous
| ||||||
25 | system, including its salts, isomers, and salts of isomers:
| ||||||
26 | (1) Fenethylline;
|
| |||||||
| |||||||
1 | (2) N-ethylamphetamine;
| ||||||
2 | (3) Aminorex (some other names:
| ||||||
3 | 2-amino-5-phenyl-2-oxazoline; aminoxaphen;
| ||||||
4 | 4-5-dihydro-5-phenyl-2-oxazolamine) and its
| ||||||
5 | salts, optical isomers, and salts of optical isomers;
| ||||||
6 | (4) Methcathinone (some other names:
| ||||||
7 | 2-methylamino-1-phenylpropan-1-one;
| ||||||
8 | Ephedrone; 2-(methylamino)-propiophenone;
| ||||||
9 | alpha-(methylamino)propiophenone; N-methylcathinone;
| ||||||
10 | methycathinone; Monomethylpropion; UR 1431) and its
| ||||||
11 | salts, optical isomers, and salts of optical isomers;
| ||||||
12 | (5) Cathinone (some trade or other names:
| ||||||
13 | 2-aminopropiophenone; alpha-aminopropiophenone;
| ||||||
14 | 2-amino-1-phenyl-propanone; norephedrone);
| ||||||
15 | (6) N,N-dimethylamphetamine (also known as:
| ||||||
16 | N,N-alpha-trimethyl-benzeneethanamine;
| ||||||
17 | N,N-alpha-trimethylphenethylamine);
| ||||||
18 | (7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
| ||||||
19 | 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
| ||||||
20 | (g) Temporary listing of substances subject to emergency | ||||||
21 | scheduling.
Any material, compound, mixture, or preparation | ||||||
22 | that contains any quantity
of the following substances:
| ||||||
23 | (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
| ||||||
24 | (benzylfentanyl), its optical isomers, isomers, salts,
| ||||||
25 | and salts of isomers;
| ||||||
26 | (2) N-[1(2-thienyl)
|
| |||||||
| |||||||
1 | methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
| ||||||
2 | its optical isomers, salts, and salts of isomers.
| ||||||
3 | (Source: P.A. 90-382, eff. 8-15-97; 91-714, eff. 6-2-00; | ||||||
4 | revised 10-18-05.)
|